Accelerate Diagnostics
AXDX
#9383
Rank
โ‚ฌ39.93 M
Marketcap
1,59ย โ‚ฌ
Share price
-2.91%
Change (1 day)
-62.23%
Change (1 year)

Accelerate Diagnostics (AXDX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚ฌ55.14 Million

According to Accelerate Diagnostics's latest financial reports the company's total liabilities are โ‚ฌ55.14 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Accelerate Diagnostics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚ฌ81.36 M-21.99%
2021-12-31โ‚ฌ0.10 B-17.89%
2020-12-31โ‚ฌ0.12 B0.35%
2019-12-31โ‚ฌ0.12 B13.23%
2018-12-31โ‚ฌ0.11 B1870.25%
2017-12-31โ‚ฌ5.67 M18.51%
2016-12-31โ‚ฌ4.78 M-16.99%
2015-12-31โ‚ฌ5.76 M84.1%
2014-12-31โ‚ฌ3.13 M126.03%
2013-12-31โ‚ฌ1.38 M
2012-07-31โ‚ฌ1.93 M92.61%
2011-07-31โ‚ฌ1 M-3.25%
2010-07-31โ‚ฌ1.04 M11.03%
2009-07-31โ‚ฌ0.93 M3.35%
2008-07-31โ‚ฌ0.9 M-1.4%
2007-07-31โ‚ฌ0.92 M5.98%
2006-07-31โ‚ฌ0.86 M-21.46%
2005-07-31โ‚ฌ1.1 M34.73%
2004-07-31โ‚ฌ0.82 M-8.31%
2003-07-31โ‚ฌ0.89 M-31.2%
2002-07-31โ‚ฌ1.3 M1.46%
2001-07-31โ‚ฌ1.28 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ48.95 B 88,664.41%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.30 B 11,335.29%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ28.37 B 51,347.52%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.97 B 5,294.62%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.31 B 463.21%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ4.07 B 7,293.08%๐Ÿ‡บ๐Ÿ‡ธ USA